CJC-1295 / Ipamorelin (5mg/5mg)
Typical dose
100 mcg each
1–2×/day · SubQ · blend
What is CJC-1295 / Ipamorelin (5mg/5mg)?
Pre-mixed blend of CJC-1295 (no DAC) 5mg and Ipamorelin 5mg in a single 10mg vial. The most popular GH-optimization stack combined for convenience. CJC-1295 provides the GHRH signal, Ipamorelin provides the GHRP pulse — together they produce synergistic GH release significantly greater than either alone.
Benefits & uses
- GH pulse stimulation
- Muscle retention
- Fat loss
- Sleep improvement
- Recovery
- Anti-aging
Blend composition
CJC-1295 (no DAC) 5mg + Ipamorelin 5mg = 10mg
Mix the 10 mg blend with 2 mL bac water → 2,500 mcg each per mL. A 0.04 mL dose = 4 units.
- CJC-1295100 mcg
- Ipamorelin100 mcg
CJC-1295 / Ipamorelin (5mg/5mg) dosage
- Typical dose
- Typical: 100 mcg of each per dose SubQ, 1–2×/day (pre-bed and/or AM). 8–12 weeks.
- Protocol notes
- Reconstitute 10mg vial with 2ml BAC water. Draw 0.1ml = 500mcg total (250mcg each). Inject fasted 30+ min before eating. Best before bed.
CJC-1295 / Ipamorelin (5mg/5mg) half-life
CJC-1295 ~30 min, Ipamorelin ~2h. Dose before bed or pre-workout fasted.
CJC-1295 / Ipamorelin (5mg/5mg) side effects
- Research use only
- Fast 30+ minutes before and after injection
- Avoid in active cancer
Warnings & monitoring
- Research use only
- Fast 30+ minutes before and after injection
- Avoid in active cancer
Preparation & storage
- Reconstitution
- Reconstitute the 10 mg blend with 2 mL BAC water → 5 mg/mL total (2.5 mg each per mL). ~100 mcg each ≈ 0.04 mL = 4 units on a U-100 syringe.
CJC-1295 / Ipamorelin (5mg/5mg) interactions
with IGF-1 LR3
Caution · moderateGH stimulates endogenous IGF-1 production; adding exogenous IGF-1 LR3 creates significant additive anabolic signaling. Hypoglycemia, acromegaly risk, and organ growth concerns at high doses.
Timing: Avoid concurrent use without medical supervision; use sequentially if at all
with Insulin
Caution · severeGH induces insulin resistance; combining with exogenous insulin creates complex glucose management requirements. Life-threatening hypoglycemia risk if dosing is incorrect.
Timing: Never combine without medical supervision and continuous glucose monitoring
Commonly stacked with
More GH Secretagogue Blend
- CJC-1295 / Ipamorelin (10mg/10mg)High-dose pre-mixed blend of CJC-1295 (no DAC) 10mg and Ipamorelin 10mg in a…
- CJC-1295 DAC / Ipamorelin (2mg/5mg)Long-acting GH blend combining CJC-1295 with Drug Affinity Complex (2mg) and…
- Tesamorelin / Ipamorelin BlendPre-mixed blend pairing Tesamorelin, a GHRH analog, with Ipamorelin, a…
